➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Mallinckrodt
McKesson
Medtronic
Dow

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Thallous chloride tl-201 - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for thallous chloride tl-201 and what is the scope of freedom to operate?

Thallous chloride tl-201 is the generic ingredient in one branded drug marketed by Bracco, Curium, Ge Healthcare, Lantheus Medcl, and Trace Life, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for thallous chloride tl-201. Three suppliers are listed for this compound.

Summary for thallous chloride tl-201
US Patents:0
Tradenames:1
Applicants:5
NDAs:6
Drug Master File Entries: 6
Suppliers / Packagers: 3
Bulk Api Vendors: 19
DailyMed Link:thallous chloride tl-201 at DailyMed
Pharmacology for thallous chloride tl-201

US Patents and Regulatory Information for thallous chloride tl-201

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Curium THALLOUS CHLORIDE TL 201 thallous chloride tl-201 INJECTABLE;INTRAVENOUS 077698-001 Nov 9, 2006 DISCN No No   Start Trial   Start Trial   Start Trial
Bracco THALLOUS CHLORIDE TL 201 thallous chloride tl-201 INJECTABLE;INJECTION 018548-001 Dec 30, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Lantheus Medcl THALLOUS CHLORIDE TL 201 thallous chloride tl-201 INJECTABLE;INJECTION 017806-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Ge Healthcare THALLOUS CHLORIDE TL 201 thallous chloride tl-201 INJECTABLE;INJECTION 018110-002 Feb 27, 1996 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Trace Life THALLOUS CHLORIDE TL 201 thallous chloride tl-201 INJECTABLE;INJECTION 075569-001 Nov 21, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
Lantheus Medcl THALLOUS CHLORIDE TL 201 thallous chloride tl-201 INJECTABLE;INTRAVENOUS 017806-002 Oct 9, 1998 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Merck
Express Scripts
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.